INTRODUCTION: Among morbidly obese adult patients (BMI >40 kg/m(2)), those who are super-super obese (BMI >60 kg/m(2)) present particular challenges for bariatric surgeons. Surgical management of super-super obese (SSO) patients has been associated with higher morbidity and mortality and increased surgical risk. The optimal surgical management of these patients is controversial. The aim of this study was to compare perioperative outcomes, percent excess weight loss (%EWL), and percent weight loss (%WL) in super-super obese patients who underwent either SG or RYGB. MATERIALS AND METHODS: This study was a nonrandomized, controlled, retrospective review of 89 SSO patients who underwent SG or RYGB at the University of Illinois Hospital and Health Sciences System from January 2008 to June 2014. Patient demographics, pre-surgical comorbidities, perioperative parameters, post-operative complications (leak, conversion to open surgery, and 30-day mortality), and post-operative outcome months were examined. RESULTS: Seventy-seven patients underwent SG (nine robotic sleeve and 68 laparoscopic sleeve gastrectomy), and 12 underwent RYGB. The mean pre-operative BMI was 63.4 kg/m(2) (SD = 3.7 kg/m(2)). The mean operative time was 88.4 min (SD = 31.7) for the SG patients and 219.2 min (SD = 80.2) for the RYGB patients. There were no significant differences in complications or length of hospitalization between the groups. There were significant differences in %EWL and %WL at 12- and 24-month follow-up between groups (p's < 0.05). CONCLUSIONS: Based on the results from this sample of patients, SG and RYGB appear to be viable procedures for the surgical management of super-super obese patients. RYGB, however, provides a significantly higher %EWL and %WL at 12 and 24 months compared to SG, which in turn, yields acceptable but lower %EWL and %WL.
INTRODUCTION: Among morbidly obese adultpatients (BMI >40 kg/m(2)), those who are super-super obese (BMI >60 kg/m(2)) present particular challenges for bariatric surgeons. Surgical management of super-super obese (SSO) patients has been associated with higher morbidity and mortality and increased surgical risk. The optimal surgical management of these patients is controversial. The aim of this study was to compare perioperative outcomes, percent excess weight loss (%EWL), and percent weight loss (%WL) in super-super obesepatients who underwent either SG or RYGB. MATERIALS AND METHODS: This study was a nonrandomized, controlled, retrospective review of 89 SSO patients who underwent SG or RYGB at the University of Illinois Hospital and Health Sciences System from January 2008 to June 2014. Patient demographics, pre-surgical comorbidities, perioperative parameters, post-operative complications (leak, conversion to open surgery, and 30-day mortality), and post-operative outcome months were examined. RESULTS: Seventy-seven patients underwent SG (nine robotic sleeve and 68 laparoscopic sleeve gastrectomy), and 12 underwent RYGB. The mean pre-operative BMI was 63.4 kg/m(2) (SD = 3.7 kg/m(2)). The mean operative time was 88.4 min (SD = 31.7) for the SG patients and 219.2 min (SD = 80.2) for the RYGB patients. There were no significant differences in complications or length of hospitalization between the groups. There were significant differences in %EWL and %WL at 12- and 24-month follow-up between groups (p's < 0.05). CONCLUSIONS: Based on the results from this sample of patients, SG and RYGB appear to be viable procedures for the surgical management of super-super obesepatients. RYGB, however, provides a significantly higher %EWL and %WL at 12 and 24 months compared to SG, which in turn, yields acceptable but lower %EWL and %WL.
Authors: Raquel Sánchez-Santos; Nuria Vilarrasa; Jorge Pujol; Pablo Moreno; Jose Manuel Francos; Antonio Rafecas; Carlos Masdevall Journal: Obes Surg Date: 2006-04 Impact factor: 4.129
Authors: Rafael M Fazylov; Richard H Savel; Joel H Horovitz; Murali K Pagala; Gene F Coppa; Jeffrey Nicastro; Richard S Lazzaro; Jerzy M Macura Journal: Obes Surg Date: 2005-05 Impact factor: 4.129
Authors: Chetan Parmar; Mohamed A Abdelhalim; Kamal K Mahawar; Maureen Boyle; William R J Carr; Neil Jennings; Peter K Small Journal: Surg Endosc Date: 2016-12-15 Impact factor: 4.584
Authors: Hassan Nasser; Tommy Ivanics; Oliver A Varban; Jonathan F Finks; Aaron Bonham; Amir A Ghaferi; Arthur M Carlin Journal: Surg Endosc Date: 2020-06-22 Impact factor: 4.584
Authors: María Belén Acevedo; Ramiro Ferrando; Bruce W Patterson; J Christopher Eagon; Samuel Klein; Marta Yanina Pepino Journal: Surg Obes Relat Dis Date: 2018-11-02 Impact factor: 4.734
Authors: Brijesh Madhok; Kamal K Mahawar; Maureen Boyle; William R J Carr; Neil Jennings; Norbert Schroeder; Shlok Balupuri; Peter K Small Journal: Obes Surg Date: 2016-07 Impact factor: 4.129
Authors: Karl Rheinwalt; Tom F Ulmer; Sophia M-T Schmitz; Patrick H Alizai; Andreas Kroh; Sandra Schipper; Jonathan F Brozat; Andreas Plamper; Ulf P Neumann Journal: Surg Endosc Date: 2021-10-26 Impact factor: 3.453
Authors: Raelina S Howell; Helen H Liu; Harika Boinpally; Meredith Akerman; Elizabeth Carruthers; Barbara M Brathwaite; Patrizio Petrone; Collin E M Brathwaite Journal: JSLS Date: 2021 Apr-Jun Impact factor: 2.172